Open Access“Doctor as a drug” in a stroke follow-up
Author(s) -
Ekaterina Aleshchenko,
В. В. Кашталап
Publication year - 2022
Publication title -
kompleksnye problemy serdečno-sosudistyh zabolevanij
Language(s) - English
Resource type - Journals
eISSN - 2587-9537
pISSN - 2306-1278
DOI - 10.17802/2306-1278-2022-11-1-107-111
Subject(s) - stroke (engine) , medicine , pandemic , covid-19 , acute stroke , emergency medicine , medical emergency , nursing , disease , emergency department , mechanical engineering , infectious disease (medical specialty) , engineering
Each year about 400 000 people in Russia get strokes. Whereas an acute treatment takes place in specialized intensive care units in hospitals, follow-up is handed over to general (rarely – private) practitioner. The majority of stroke survivors show low adherence to follow-up resulting in repeated hospitalizations and growth of multi-morbidity burden. With COVID-19 pandemic negatively affecting availability of medical services and increasing health risks for stroke survivors, a physician-patient relation becomes the means of persuading patients to healthpromoting behaviour.